1) U.S. Preventive Services Task Force:Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility:recommendation statement. Ann Intern Med 143:355-361, 2005
2) U.S. Preventive Services Task Force:Chemoprevention of breast cancer:recommendations and rationale. Ann Intern Med 137:56-58, 2002
3) Gail MH, et al:Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer. J Natl Cancer Inst 91:1829-1846, 1999
4) U.S. Preventive Services Task Force:Screening for breast cancer:recommendations and rationale. Ann Intern Med 137:344-346, 2002
5) 津金昌一郎:がん罹患ハイリスク群の臨床―疫学研究に基づくがん罹患ハイリスク群の設定.成人病と生活習慣病37(11):1205-1211, 2007
6) Olsen O, et al:Cochrane review on screening for breast cancer with mammography. Lancet 358:1340-1342, 2001
7) 矢野栄二・他:EBM健康診断.苅田香苗:職域における健診項目の検討-女性の健康診断2.乳がん,pp181-187, 医学書院,2003
8) Calvocoressi L, et al:Mammography screening of women in their 40s:impact of changes in screening guidelines. Cancer 112(3):473-480, 2007
9) Lehman CD, et al:Cancer yield of mammography, MR, and US in high-risk women;prospective multi-institution breast cancer screening study. Radiology 244:381-388, 2007
10) 柄松章司・他:超音波による検診は乳癌死亡率を減少させるか? 超音波発見乳癌のマンモグラフィ所見からの考察.日本乳癌検診学会誌16(1):79-84, 2007
11) Kuhl CK, et al:MRI for diagnosis of pure ductal carcinoma in situ:a prospective observational study. Lancet 370:485-492, 2007
12) Semiglazov VF, et al:Results of a prospective randomized investigation[Russia(St. Petersburg)/WHO]to evaluate the significance of self-examination for the early detection of breast cancer. Vopr Onkol 49(4):434-441, 2003